Rational Vaccine Design in the Time of COVID-19
As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses includin...
Gespeichert in:
| Veröffentlicht in: | Cell host & microbe 2020-05, Vol.27 (5), p.695-698 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 698 |
|---|---|
| container_issue | 5 |
| container_start_page | 695 |
| container_title | Cell host & microbe |
| container_volume | 27 |
| creator | Burton, Dennis R Walker, Laura M |
| description | As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses. |
| doi_str_mv | 10.1016/j.chom.2020.04.022 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7219357</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2404043843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-caabe00390609410ccfb5c51caf0d0b5265c682e81629379c2a3fc6ed3cd24763</originalsourceid><addsrcrecordid>eNpVkE1Lw0AQhhdRbK3-AQ-So5eks9_NRZDWj0KhILXXZbPZtFuSbM2mgv_e1NaizGEG5p13Zh6EbjEkGLAYbhKz9lVCgEACLAFCzlAfp5TFAkR6_lPjmGIy6qGrEDYAnIPEl6hHCQMpQfbR8E23zte6jJbaGFfbaGKDW9WRq6N2baOFq2zki2g8X04nMU6v0UWhy2BvjnmA3p-fFuPXeDZ_mY4fZ7HhjLex0TqzADQFASnDYEyRccOx0QXkkHEiuBEjYkdYkJTK1BBNCyNsTk1OmBR0gB4OvttdVtnc2LptdKm2jat086W8dup_p3ZrtfKfSpLuay47g_ujQeM_dja0qnLB2LLUtfW7oDoCXdARo52UHKSm8SE0tjitwaD2pNVG7UmrPWkFTHWku6G7vweeRn7R0m-NQ3k3</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404043843</pqid></control><display><type>article</type><title>Rational Vaccine Design in the Time of COVID-19</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Burton, Dennis R ; Walker, Laura M</creator><creatorcontrib>Burton, Dennis R ; Walker, Laura M</creatorcontrib><description>As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses.</description><identifier>ISSN: 1931-3128</identifier><identifier>EISSN: 1934-6069</identifier><identifier>DOI: 10.1016/j.chom.2020.04.022</identifier><identifier>PMID: 32407707</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>AIDS Vaccines - immunology ; AIDS Vaccines - standards ; Antibodies, Viral - immunology ; Antigens, Viral - immunology ; Betacoronavirus - immunology ; Coronavirus Infections - immunology ; Coronavirus Infections - prevention & control ; COVID-19 ; COVID-19 Vaccines ; Forum ; Humans ; Influenza Vaccines - immunology ; Influenza Vaccines - standards ; Pandemics - prevention & control ; Pneumonia, Viral - immunology ; Pneumonia, Viral - prevention & control ; Research Design - trends ; SARS-CoV-2 ; Viral Vaccines - immunology</subject><ispartof>Cell host & microbe, 2020-05, Vol.27 (5), p.695-698</ispartof><rights>Copyright © 2020 Elsevier Inc. All rights reserved.</rights><rights>2020 Elsevier Inc. 2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-caabe00390609410ccfb5c51caf0d0b5265c682e81629379c2a3fc6ed3cd24763</citedby><cites>FETCH-LOGICAL-c545t-caabe00390609410ccfb5c51caf0d0b5265c682e81629379c2a3fc6ed3cd24763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32407707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burton, Dennis R</creatorcontrib><creatorcontrib>Walker, Laura M</creatorcontrib><title>Rational Vaccine Design in the Time of COVID-19</title><title>Cell host & microbe</title><addtitle>Cell Host Microbe</addtitle><description>As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses.</description><subject>AIDS Vaccines - immunology</subject><subject>AIDS Vaccines - standards</subject><subject>Antibodies, Viral - immunology</subject><subject>Antigens, Viral - immunology</subject><subject>Betacoronavirus - immunology</subject><subject>Coronavirus Infections - immunology</subject><subject>Coronavirus Infections - prevention & control</subject><subject>COVID-19</subject><subject>COVID-19 Vaccines</subject><subject>Forum</subject><subject>Humans</subject><subject>Influenza Vaccines - immunology</subject><subject>Influenza Vaccines - standards</subject><subject>Pandemics - prevention & control</subject><subject>Pneumonia, Viral - immunology</subject><subject>Pneumonia, Viral - prevention & control</subject><subject>Research Design - trends</subject><subject>SARS-CoV-2</subject><subject>Viral Vaccines - immunology</subject><issn>1931-3128</issn><issn>1934-6069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkE1Lw0AQhhdRbK3-AQ-So5eks9_NRZDWj0KhILXXZbPZtFuSbM2mgv_e1NaizGEG5p13Zh6EbjEkGLAYbhKz9lVCgEACLAFCzlAfp5TFAkR6_lPjmGIy6qGrEDYAnIPEl6hHCQMpQfbR8E23zte6jJbaGFfbaGKDW9WRq6N2baOFq2zki2g8X04nMU6v0UWhy2BvjnmA3p-fFuPXeDZ_mY4fZ7HhjLex0TqzADQFASnDYEyRccOx0QXkkHEiuBEjYkdYkJTK1BBNCyNsTk1OmBR0gB4OvttdVtnc2LptdKm2jat086W8dup_p3ZrtfKfSpLuay47g_ujQeM_dja0qnLB2LLUtfW7oDoCXdARo52UHKSm8SE0tjitwaD2pNVG7UmrPWkFTHWku6G7vweeRn7R0m-NQ3k3</recordid><startdate>20200513</startdate><enddate>20200513</enddate><creator>Burton, Dennis R</creator><creator>Walker, Laura M</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200513</creationdate><title>Rational Vaccine Design in the Time of COVID-19</title><author>Burton, Dennis R ; Walker, Laura M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-caabe00390609410ccfb5c51caf0d0b5265c682e81629379c2a3fc6ed3cd24763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AIDS Vaccines - immunology</topic><topic>AIDS Vaccines - standards</topic><topic>Antibodies, Viral - immunology</topic><topic>Antigens, Viral - immunology</topic><topic>Betacoronavirus - immunology</topic><topic>Coronavirus Infections - immunology</topic><topic>Coronavirus Infections - prevention & control</topic><topic>COVID-19</topic><topic>COVID-19 Vaccines</topic><topic>Forum</topic><topic>Humans</topic><topic>Influenza Vaccines - immunology</topic><topic>Influenza Vaccines - standards</topic><topic>Pandemics - prevention & control</topic><topic>Pneumonia, Viral - immunology</topic><topic>Pneumonia, Viral - prevention & control</topic><topic>Research Design - trends</topic><topic>SARS-CoV-2</topic><topic>Viral Vaccines - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burton, Dennis R</creatorcontrib><creatorcontrib>Walker, Laura M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cell host & microbe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burton, Dennis R</au><au>Walker, Laura M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rational Vaccine Design in the Time of COVID-19</atitle><jtitle>Cell host & microbe</jtitle><addtitle>Cell Host Microbe</addtitle><date>2020-05-13</date><risdate>2020</risdate><volume>27</volume><issue>5</issue><spage>695</spage><epage>698</epage><pages>695-698</pages><issn>1931-3128</issn><eissn>1934-6069</eissn><abstract>As scientists consider SARS-CoV-2 vaccine design, we discuss problems that may be encountered and how to tackle them by what we term "rational vaccine design." We further discuss approaches to pan-coronavirus vaccines. We draw on experiences from recent research on several viruses including HIV and influenza, as well as coronaviruses.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32407707</pmid><doi>10.1016/j.chom.2020.04.022</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1931-3128 |
| ispartof | Cell host & microbe, 2020-05, Vol.27 (5), p.695-698 |
| issn | 1931-3128 1934-6069 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7219357 |
| source | MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | AIDS Vaccines - immunology AIDS Vaccines - standards Antibodies, Viral - immunology Antigens, Viral - immunology Betacoronavirus - immunology Coronavirus Infections - immunology Coronavirus Infections - prevention & control COVID-19 COVID-19 Vaccines Forum Humans Influenza Vaccines - immunology Influenza Vaccines - standards Pandemics - prevention & control Pneumonia, Viral - immunology Pneumonia, Viral - prevention & control Research Design - trends SARS-CoV-2 Viral Vaccines - immunology |
| title | Rational Vaccine Design in the Time of COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A04%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rational%20Vaccine%20Design%20in%20the%20Time%20of%20COVID-19&rft.jtitle=Cell%20host%20&%20microbe&rft.au=Burton,%20Dennis%20R&rft.date=2020-05-13&rft.volume=27&rft.issue=5&rft.spage=695&rft.epage=698&rft.pages=695-698&rft.issn=1931-3128&rft.eissn=1934-6069&rft_id=info:doi/10.1016/j.chom.2020.04.022&rft_dat=%3Cproquest_pubme%3E2404043843%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404043843&rft_id=info:pmid/32407707&rfr_iscdi=true |